LENVIMA (lenvatinib) Patient Assistance Program
Don’t let the high cost of brand specialty cancer therapy stand between you and the treatment you need. We help eligible patients access Lenvima (lenvatinib) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Lenvima (lenvatinib) is FDA-approved across several cancers — differentiated thyroid cancer (DTC) refractory to radioactive iodine, advanced renal cell carcinoma in combination with pembrolizumab or everolimus, unresectable hepatocellular carcinoma (first-line), and advanced endometrial carcinoma in combination with pembrolizumab.
- Without assistance, the retail cost commonly runs approximately $22,000–$26,000 per 30-day supply at standard maintenance doses.
- Through AffordMyPrescriptions, qualifying patients can access Lenvima for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic version of Lenvima available in the U.S. as of 2026.
What is Lenvima Prescription Assistance Program?
The Lenvima Prescription Assistance Program is a manufacturer-sponsored initiative that provides Lenvima at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for cancer patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries who cannot afford specialty multi-kinase inhibitor therapy.
Navigating the program on your own means dealing with eligibility verification, oncology-team coordination, specialty pharmacy logistics, and renewal deadlines — all while managing advanced cancer treatment.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, Lenvima costs roughly $22,000–$26,000 per 30-day supply at retail pharmacies. Discount coupons offer little relief at this price level. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$25,500.00 | Save ~$25,430/mo |
| CVS Pharmacy | ~$26,000.00 | Save ~$25,930/mo |
| Walmart | ~$23,500.00 | Save ~$23,430/mo |
| Costco | ~$22,800.00 | Save ~$22,730/mo |
| Specialty Pharmacy | ~$23,000.00 | Save ~$22,930/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Lenvima Prescription Program?
The Patient Assistance Program is free to apply for and provides Lenvima at no medication cost if approved. But the process involves detailed applications, oncology-team coordination, specialty pharmacy logistics, and ongoing renewal management. Our $69.95/month service covers full advocacy: applications, doctor coordination, documentation, refill management, and annual re-enrollment — so you focus on your treatment, not paperwork.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Lenvima:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $22,000–$26,000 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Lenvima assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Lenvima Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Lenvima:
Lenvima (lenvatinib) is an oral, targeted multi-kinase inhibitor used to treat several advanced cancers — differentiated thyroid cancer that is refractory to radioactive iodine, advanced renal cell carcinoma (in combination with pembrolizumab or everolimus), unresectable hepatocellular carcinoma as first-line therapy, and advanced endometrial carcinoma in combination with pembrolizumab.
How It Works:
Lenvima is a multi-kinase inhibitor that blocks multiple receptors simultaneously, including those responsible for tumor blood-vessel formation and cell growth. By interrupting these specific signaling pathways, the drug effectively slows down the progression of the cancer. It is designed to be taken daily for as long as the patient responds well to the treatment and can tolerate it.
Form and Use:
The medication is an oral capsule taken once daily, with or without food. Starting doses vary significantly based on the type of cancer being treated, ranging from 8 mg to 24 mg, and may be used in combination with other therapies. Your oncology team will provide personalized care by adjusting the dosage based on your side effects, blood pressure, or organ function.
Generic Availability:
As of 2026, there is no FDA-approved generic version of Lenvima in the U.S. because patent and exclusivity protections are still active. While other targeted therapies and multi-kinase inhibitors exist for similar conditions, they are not direct generic replacements. Whether an alternative is appropriate depends on your specific diagnosis and prior treatment history as determined by your oncology team.
Warnings:
A primary concern with Lenvima is hypertension, which is common and often requires additional blood-pressure medication. Other serious risks include heart and liver toxicity, kidney failure, gastrointestinal perforation, and issues with wound healing. To ensure safety, your medical team will regularly monitor your blood pressure, blood counts, and kidney and liver function throughout your treatment.
FAQ (Frequently Asked Questions)
How Much Does Lenvima Cost Without Insurance?
The retail price commonly runs $22,000–$26,000 per 30-day supply at standard maintenance doses. Coupon discounts at major pharmacies exist but are modest because the underlying price is so high. Through AffordMyPrescriptions, qualifying patients receive Lenvima at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Lenvima Taken?
Lenvima is taken by mouth once daily, with or without food. The starting dose varies by indication: 24 mg for thyroid cancer, 20 mg with pembrolizumab for RCC or endometrial cancer, and 8 or 12 mg (weight-based) for hepatocellular carcinoma. Your oncology team will adjust dosing as needed for side effects.
Are There Other Multi-Kinase Inhibitors I Should Know About?
Yes. Other targeted therapies are FDA-approved for the cancer types Lenvima treats, including sorafenib, sunitinib, cabozantinib, and others. Whether one is a clinical fit depends on the indication, prior treatments, and biomarker status. We mention this directly because if a different therapy on a more accessible assistance pathway would work for your situation, that may be a better path.
Can I Get Lenvima Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify for Lenvima Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If your initial application is denied, we explore alternative savings paths on your behalf — including independent oncology-focused foundations such as the PAN Foundation or HealthWell Foundation, disease-specific organizations (Thyroid Cancer Survivors’ Association, Kidney Cancer Association, etc.), the manufacturer’s copay savings program if you have commercial insurance, or asking your oncology team whether a different targeted therapy would be appropriate. If we cannot find a path, you will not be charged our service fee.
How Long Does It Take To Get Approved?
Most enrolled patients receive their first Lenvima shipment within two to four weeks of completing the documentation. Timing depends on how quickly your oncology team returns the required forms and the specialty pharmacy completes intake.
Take Control of Your Medication Costs
If you are struggling with the high cost of Lenvima, our team may be able to help you access assistance programs designed to make brand specialty cancer therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.